COX-2 targeted therapy for diabetic foot ulcers using T7-enhanced CS-PVA membranes.
Murugan R, Ashok K, Ramya Ranjan Nayak SP, Deivasigamani P, Almutairi MH, Almutairi BO, Guru A, Muthu Kumaradoss K, Arockiaraj J.
Murugan R, et al. Among authors: arockiaraj j.
Int Immunopharmacol. 2024 Dec 25;143(Pt 1):113206. doi: 10.1016/j.intimp.2024.113206. Epub 2024 Sep 30.
Int Immunopharmacol. 2024.
PMID: 39353389